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Introduction {#sec001}
============

*Chlamydia trachomatis* (CT) and *Neisseria gonorrhoeae* (NG) are the first and second most common bacterial sexually transmitted infections (STIs), with a global incidence of respectively 127.2 million and 86.9 million in 2016.\[[@pone.0234261.ref001]\] CT and NG usually colonize and infect the human reproductive tract; if left untreated or improperly treated, they can lead to severe complications, such as penile stricture and epididymitis in men, pelvic inflammatory disease and endometritis in women, and eventually lead to infertility in both genders.\[[@pone.0234261.ref002]\] Furthermore, NG and CT infections are also risk factors associated with the transmission and infection of HIV.\[[@pone.0234261.ref003]\] In the US, medical costs for gonorrhea and chlamydia are estimated at \$162.1 and \$516.7 million, respectively.\[[@pone.0234261.ref004]\]

However, due to differences in the distribution of risk factors, the prevalence and burden of STIs vary widely around the world. Shenzhen is a newly developed city with the floating population accounting for about 87% of the total population,\[[@pone.0234261.ref005]\] which makes it very likely to be a hotbed for STIs. The latest molecular epidemiological study on genital NG and CT infections conducted by Zhang et al\[[@pone.0234261.ref006]\] in Shenzhen in 2009 showed that the prevalence of CT and NG among participants presenting to clinics was 17.7% and 9.7%, respectively. The prevalence of CT and NG observed in this study was considerably higher than the results in the Chinese Health and Family Life Survey where the overall prevalence of CT and NG infections was 2.6% and 0.08% in women, and 2.1% and 0.02% in men, respectively.\[[@pone.0234261.ref007]\] Therefore, Shenzhen may be an appropriate place to study risk factors associated with STIs, and evidence-based interventions to reduce the burden of STIs in Shenzhen may be more cost-effective. However, Zhang and colleagues' study lacks important information, such as the prevalence and proportion of asymptomatic cases and risk factors for asymptomatic infections. Asymptomatic infections will undoubtedly further facilitate the spread of gonorrhea and chlamydia, because people with gonorrhea/chlamydia but no symptoms are less likely to seek any treatment. In addition, knowledge of the burden and risk factors of asymptomatic STIs may have implications for syndromic management which is the primary care for the detection and treatment of suspected STI infections in resource-limited settings.\[[@pone.0234261.ref008], [@pone.0234261.ref009]\] At present, the effectiveness of syndromic management on reduction of the prevalence of STI infections is not satisfactory.\[[@pone.0234261.ref010]--[@pone.0234261.ref012]\] The reason is not only because of its poor sensitivity, but more importantly, most STI infections such as CT and NG are asymptomatic.

Here we investigate the prevalence and proportion of laboratory-confirmed urethral CT and/or NG infections that were asymptomatic among individuals presenting to clinics in Shenzhen and the risk factors related to asymptomatic CT infection. Given the limited health resources, there is currently no guidelines for chlamydia and gonorrhea screening in China. The findings from this study may help us to ensure proper resource allocation and develop intervention activities.

Materials and methods {#sec002}
=====================

Sampling methods and recruitment {#sec003}
--------------------------------

Participants in our study were recruited from 1 April to 16 May 2018 by using the stratified purposive sampling method. First, based on the number of NG and CT cases reported in Shenzhen in 2017, we selected the 6 administrative districts with the largest number of reported cases from the 10 administrative districts in Shenzhen. Then, in each of the selected districts, four hospitals with a high number of reported cases were included, except 1 district with only 2 hospitals. Finally, a total of 22 hospitals including 49 departments (including department of dermatology, department of urology and department of obstetrics and gynecology) were selected as study sites to include in this study. During the study period, the first 15 eligible individuals who arrived at each department every working day were invited to participate in the questionnaire survey and urine collection. The criteria for eligible participants were: (1) age ≥ 18 years; (2) having ever engaged in sexual activity; and (3) having not used any antibiotics in the last 2 weeks. The symptomatic infection was defined as the appearance of symptoms associated with gonorrhea or chlamydia infections, such as urethral discharge, vaginal discharge, dysuria or cervicitis. Ethical approval was provided by the Ethics Committee of Shenzhen Center for Chronic Disease Control (Approval No. 20180206). Written informed consent was obtained from all the participants.

Data collection {#sec004}
---------------

The anonymous questionnaire was designed by the correspondent, with a total of 45 questions, and was conducted in Chinese only. Data were obtained on: socio-demographic characteristics (including age, gender, children, residency, local residence time, marital status, education, living arrangements status, insurance and occupation), sexual orientation, risky sexual behaviors, history of STI testing, history of STI infections, STI-related knowledge/attitude and self-reported symptoms related to STIs. After a preliminary questionnaire interview, a clinical examination was carried out for each patient. Information on symptoms (dysuria, painful urination, urethral discharge, etc.) was recorded. Subsequently, each eligible participant was invited to donate a urine specimen for CT and NG testing.

Specimen collection and laboratory testing {#sec005}
------------------------------------------

15-30ml urine specimens were collected using the Cobas^®^urine specimen collection kit (Roche P/N 05170486190). These specimens were temporarily stored at 4°C in local laboratories for up to 10 days before being transported to the central laboratory for testing. In the central laboratory, we used the MagNA Pure 96 System (Roche, Switzerland) to extract and purify DNA from urine specimens by an automated magnetic nucleic acid isolation method. Then, polymerase chain reaction (PCR) of the Cobas 4800^®^ System (Roche, Switzerland) was performed using DNA extracted from urine specimens for testing CT and NG. Laboratory tests of CT and NG were performed based on standard procedures. Positive PCR results were confirmed as corresponding NG or CT infections.

Statistical analyses {#sec006}
--------------------

Considering the differences in symptomatic performance between men and women (especially with regard to asymptomatic infections), this study was stratified by gender. Descriptive analysis was conducted to describe frequencies and percentages of key variables, and to calculate the prevalence of asymptomatic gonorrhea or chlamydia. Statistical differences between asymptomatic NG or CT patients and non-patients for the categorical variables were assessed using Chi-square test and Fisher exact test as appropriate. Univariate logistic regressions were used to select appropriate variables for the multivariate logistic regression models. Those variables with *p*-value \< 0.2 were included in the multivariate analyses to further examine the association between males/females with asymptomatic urethral NG and/or CT, and potential risk factors. Adjusted odds ratios (AORs) and their corresponding 95% confidence interval (CI) were calculated to measure the correlation strength. *P*-values \< 0.05 were considered statistically significant. All analysis above were performed using SPSS 19.0.

Results {#sec007}
=======

Prevalence and proportion of asymptomatic NG and/or CT infections {#sec008}
-----------------------------------------------------------------

Between April 2018 and May 2018, 8,309 eligible individuals were invited to participate in this study. Of these, 7070 participants completed the questionnaire and provided urine specimens for molecular detection of NG and CT, so the survey response rate was 85.1%. The characteristics of all participants were shown in [Table 1](#pone.0234261.t001){ref-type="table"}. In total, 182 (2.6%) participants were positive for NG and 648 (9.2%) for CT. The proportion of participants without symptoms was 2871/7070 (40.6%): 1120 (39.0%) for men and 1751 (61.0%) for women. By symptomatology, urogenital NG was detected in 17 of 2871 asymptomatic participants (0.6%), and urogenital CT was detected in 207 of 2871 asymptomatic participants (7.2%). Among men reporting no symptoms, the prevalence of NG and CT was 0.9% and 6.2%, respectively. Among women reporting no symptoms, the prevalence of NG and CT was 0.4% and 7.9%, respectively ([Fig 1](#pone.0234261.g001){ref-type="fig"}). The proportion of asymptomatic NG or CT infections was shown in [Table 2](#pone.0234261.t002){ref-type="table"}.

![Prevalence of asymptomatic Gonorrhea and Chlamydia infections by Gender.](pone.0234261.g001){#pone.0234261.g001}

10.1371/journal.pone.0234261.t001

###### Characteristics of all participants.

![](pone.0234261.t001){#pone.0234261.t001g}

  Variables                                            N (%)
  ---------------------------------------------------- -------------
  Age, y                                               
   ≤30                                                 2934 (41.5)
   \>30                                                4136 (58.5)
  Gender                                               
   Male                                                2258 (31.9)
   female                                              4812 (68.1)
  Children                                             
   No                                                  2679 (37.9)
   Yes                                                 4338 (61.4)
  Living arrangements status                           
   Living alone                                        591 (8.4)
   Living with spouse                                  4716 (66.7)
  Residence status                                     
   Local residents                                     1858 (26.3)
   Migrants                                            5212 (73.7)
  Local residence time                                 
   0--12 months                                        775 (11.0)
   Over 1 year                                         6295 (89.0)
  Occupation                                           
   Staff                                               1803 (25.5)
   Commercial services                                 1529 (21.6)
   Housework or unemployed                             1063 (15.0)
   Worker                                              1780 (25.2)
  Highest educational level                            
   Lower than senior high school                       4268 (60.4)
   Senior high school and above                        2802 (39.6)
  Clinical settings                                    
   Dermatological department                           1018 (14.4)
   Gynecological department                            4136 (58.5)
   Urological department                               1274 (18.0)
   Family planning department                          624 (8.8)
  Insurance                                            
   Private/Medicaid                                    4408 (62.3)
   Uninsured                                           2662 (37.7)
  Sex with an anonymous partner in the last 3 months   
   Yes                                                 2580 (36.5)
   No                                                  4490 (63.5)
  History of STI infections                            
   No                                                  5966 (84.4)
   Yes                                                 1104 (15.6)
  History of STI testing                               
   No                                                  6479 (91.6)
   Yes                                                 591 (8.4)
  STI-related knowledge                                
   Low                                                 5594 (79.1)
   High                                                1476 (20.9)
  Partner notification                                 
   No                                                  729 (10.3)
   Yes                                                 6121 (86.6)

10.1371/journal.pone.0234261.t002

###### Gonorrhea and Chlamydia positive rate and proportion among 7070 STI clinic attenders stratified by sex and symptoms.

![](pone.0234261.t002){#pone.0234261.t002g}

              Number tested (%)   Number +ve (%)   Gonorrhea         Chlamydia                         
  ----------- ------------------- ---------------- ----------------- --------------- ----------------- -----------------
  Male        2258 (31.9)         343 (15.2)       129 (92.8%)       10 (7.2%)       175 (71.7%)       69 (28.3%)
  Female      4812 (68.1)         426 (8.9)        36 (83.7%)        7 (16.3%)       266 (65.8%)       138 (34.2%)
  **Total**   **7070 (100)**      **769 (10.9)**   **165 (90.7%)**   **17 (9.3%)**   **441 (68.1%)**   **207 (31.9%)**

Characteristics of asymptomatic male participants {#sec009}
-------------------------------------------------

Of the 1120 asymptomatic male participants included in this analysis, 60.0% were over 30 of age; 73.7% were immigrants (unregistered residents of Shenzhen); 92.6% lived in Shenzhen for more than one year; 50.9% had education at the senior high school level or higher; 49.5% had had sex with an anonymous partner in the past 3 months; 87.5% had no history of STI infections; 91.2% had no history of STI testing and 77.6% had a low level of STI-related knowledge ([Table 3](#pone.0234261.t003){ref-type="table"}).

10.1371/journal.pone.0234261.t003

###### Characteristics of asymptomatic male participants in Shenzhen, China.

![](pone.0234261.t003){#pone.0234261.t003g}

                                                                                       Asymptomatic Male participants                            
  ---------------------------------------------------- ------------------------------- -------------------------------- ------------ ----------- --------------
  Age, y                                               ≤30                             448 (40.0)                       410 (39.0)   38 (55.1)   **0.008**
                                                       \>30                            672 (60.0)                       641 (61.0)   31 (44.9)   
  Children                                             No                              606 (54.1)                       569 (54.1)   37 (53.6)   0.292
                                                       Yes                             510 (45.5)                       479 (45.6)   31 (44.9)   
  Living arrangements status                           Living alone                    144 (12.9)                       138 (13.1)   6 (8.7)     0.079
                                                       Living with spouse              651 (58.1)                       616 (58.6)   35 (50.7)   
  Residence status                                     Local residents                 295 (26.3)                       281 (26.7)   14 (20.3)   0.239
                                                       Migrants                        825 (73.7)                       770 (73.3)   55 (79.7)   
  Local residence time                                 0--12 months                    83 (7.4)                         77 (7.3)     6 (8.7)     0.674
                                                       Over 1 year                     1037 (92.6)                      974 (92.7)   63 (91.3)   
  Occupation                                           Staff                           330 (29.5)                       319 (30.4)   11 (15.9)   **0.010**
                                                       Commercial services             304 (27.1)                       277 (26.4)   27 (39.1)   
                                                       Housework or unemployed         12 (1.1)                         11 (1.0)     1 (1.4)     
                                                       Worker                          334 (29.8)                       318 (30.3)   16 (23.2)   
  Highest educational level                            Lower than senior high school   550 (49.1)                       510 (48.5)   40 (58.0)   0.128
                                                       Senior high school and above    570 (50.9)                       541 (51.5)   29 (42.0)   
  Clinical settings                                    Dermatological department       362 (32.3)                       345 (32.8)   17 (24.6)   **\< 0.001**
                                                       Urological department           536 (47.9)                       490 (46.6)   46 (66.7)   
                                                       Family planning department      220 (19.6)                       215 (20.5)   5 (7.2)     
  Insurance                                            Private/Medicaid                724 (64.6)                       685 (65.2)   39 (56.5)   0.145
                                                       uninsured                       396 (35.4)                       366 (34.8)   30 (43.5)   
  Sex with an anonymous partner in the last 3 months   Yes                             554 (49.5)                       516 (49.1)   38 (55.1)   0.336
                                                       No                              566 (50.5)                       535 (50.9)   31 (44.9)   
  History of STI infections                            No                              980 (87.5)                       920 (87.5)   60 (87.0)   0.790
                                                       Yes                             63 (5.7)                         58 (5.5)     5 (7.2)     
  History of STI testing                               No                              1021 (91.2)                      956 (91.0)   65 (94.2)   0.358
                                                       Yes                             99 (8.8)                         95 (9.0)     4 (5.8)     
  STI-related knowledge                                Low                             869 (77.6)                       817 (77.7)   52 (75.4)   0.647
                                                       High                            251 (22.4)                       234 (22.3)   17 (24.6)   
  Partner notification                                 No                              92 (8.2)                         86 (8.2)     6 (8.7)     0.493
                                                       Yes                             1007 (89.9)                      944 (89.8)   63 (91.3)   

Because of the low prevalence of NG in our study, we only described the results of factor analysis of asymptomatic CT infection. When compared with normal people, there were more asymptomatic men infected with CT in participants under 30 years of age (55.1% vs 39.0%), who were employed in commercial service work (39.1% vs 26.4%) and who were recruited through the urological department (66.7% vs 44.6%) ([Table 3](#pone.0234261.t003){ref-type="table"}).

Factors associated with asymptomatic CT infection among male participants {#sec010}
-------------------------------------------------------------------------

Risk factors associated with asymptomatic CT infection among male participants included males aged less than 30 years (aOR, 1.83; 95% CI, 1.11--3.03), being employed in commercial service work (2.82; 1.36--5.84) and being recruited through urological department (vs dermatological department, 2.12; 1.19--3.79) ([Table 4](#pone.0234261.t004){ref-type="table"}).

10.1371/journal.pone.0234261.t004

###### Factors associated with asymptomatic CT infections among male participants.

![](pone.0234261.t004){#pone.0234261.t004g}

  Variables                        Univariate analysis   Multivariate analysis                           
  -------------------------------- --------------------- ----------------------- ----------------------- -----------
  Age, y                                                                                                 
   \>30                            1                                             **1**                   
   ≤30                             1.92 (1.17--3.12)     0.009                   **1.83 (1.11--3.03)**   **0.019**
  Occupation                                                                                             
   Staff                           1                                             1                       
   Commercial services             2.83 (1.38--5.80)     0.005                   **2.82 (1.36--5.84)**   **0.005**
   Housework or unemployed         2.64 (0.31--22.26)    0.373                   ―                       ―
   Worker                          1.46 (0.67--3.19)     0.344                   ―                       ―
  Highest educational level                                                                              
   Lower than senior high school   1                                             1                       
   Senior high school and above    0.68 (0.42--1.12)     0.130                   0.74 (0.42--1.30)       0.291
  Clinical settings                                                                                      
   Dermatological department       1                                             1                       
   Urological department           1.91 (1.07--3.38)     0.027                   **2.12 (1.19--3.79)**   **0.011**
   Family planning department      0.47 (0.17--1.30)     0.146                   0.49 (0.18--1.36)       0.172
  Insurance                                                                                              
   Private/Medicaid                1                                             1                       
   Uninsured                       1.44 (0.88--2.36)     0.147                   0.94 (0.54--1.66)       0.842

Characteristics of asymptomatic female participants {#sec011}
---------------------------------------------------

Of the1751 asymptomatic female participants included in this analysis, 59.0% were more than 30 years old;70.0% were immigrants (unregistered residents of Shenzhen); 90.6% lived in Shenzhen for more than one year; 70.5% had education at the senior high school level or higher; 26.4% had had sex with an anonymous partner in the last 3 months; 85.5% had no history of STI infections; 91.3% had no history of STI testing and 80.4% had a low level of STI-related knowledge ([Table 5](#pone.0234261.t005){ref-type="table"}).

10.1371/journal.pone.0234261.t005

###### Characteristics of asymptomatic female participants.

![](pone.0234261.t005){#pone.0234261.t005g}

                                                                                       Asymptomatic Female Participants                              
  ---------------------------------------------------- ------------------------------- ---------------------------------- ------------- ------------ --------------
  Age, y                                               ≤30                             718 (41.0)                         641 (39.7)    77 (55.8)    **\< 0.001**
                                                       \>30                            1033 (59.0)                        972 (60.3)    61 (44.2)    
  Children                                             NO                              609 (34.8)                         547 (33.9)    62 (44.9)    **0.019**
                                                       Yes                             1128 (64.4)                        1054 (65.3)   74 (53.6)    
  Living arrangements status                           Living alone                    114 (6.5)                          104 (6.4)     10 (7.2)     0.220
                                                       Living with spouse              1325 (75.7)                        1247 (77.3)   78 (56.5)    
  Residence status                                     Local residents                 525 (30.0)                         499 (30.9)    26 (18.8)    **0.003**
                                                       Migrants                        1226 (70.0)                        1114 (69.1)   112 (81.2)   
  Local residence time                                 0--12 months                    165 (9.4)                          147 (9.1)     18 (13.0)    0.130
                                                       Over 1 year                     1586 (90.6)                        1466 (90.9)   120 (87.0)   
  Occupation                                           Staff                           492 (28.1)                         460 (28.5)    32 (23.2)    **0.017**
                                                       Commercial services             336 (19.2)                         300 (18.6)    36 (26.1)    
                                                       Housework or unemployed         375 (21.4)                         351 (21.8)    24 (17.4)    
                                                       Worker                          279 (15.9)                         248 (15.4)    31 (22.5)    
  Highest educational level                            Lower than senior high school   516 (29.5)                         465 (28.9)    53 (38.4)    0.320
                                                       Senior high school and above    1235 (70.5)                        1144 (71.1)   85 (61.6)    
  Clinical settings                                    dermatological department       75 (4.3)                           65 (4.0)      10 (7.2)     0.260
                                                       gynecological department        1367 (78.1)                        1259 (78.1)   108 (78.3)   
                                                       Family planning department      276 (15.8)                         259 (16.1)    17 (12.3)    
  Insurance                                            Private/Medicaid                1140 (65.1)                        1061 (65.8)   79 (57.2)    **0.044**
                                                       Uninsured                       611 (34.9)                         552 (34.2)    59 (42.8)    
  Sex with an anonymous partner in the last 3 months   Yes                             463 (26.4)                         423 (26.2)    40 (29.0)    0.482
                                                       No                              1288 (73.6)                        1190 (73.8)   98 (71.0)    
  History of STI infections                            No                              1497 (85.5)                        1377 (85.4)   120 (87.0)   0.862
                                                       Yes                             76 (4.3)                           71 (4.4)      5 (3.6)      
  History of STI testing                               No                              1599 (91.3)                        1467 (90.9)   132 (95.7)   0.059
                                                       Yes                             152 (8.7)                          146 (9.1)     6 (4.3)      
  STI-related knowledge                                Low                             1407 (80.4)                        1286 (79.7)   121 (87.7)   **0.025**
                                                       High                            344 (19.6)                         327 (20.3)    17 (12.3)    
  Partner notification                                 No                              88 (5.0)                           79 (4.9)      9 (6.5)      0.396
                                                       Yes                             1594 (91.0)                        1468 (91.0)   126 (91.3)   

When compared with non-patients, there were more asymptomatic women infected with CT in participants under 30 years of age (55.8% vs 39.7%), who had no children (44.9% vs 33.9%), who were migrants (81.2% vs 69.1), and uninsured (42.8% vs 34.2%). In addition, most women with CT infection were employed in commercial service work (26.1% vs 18.6%), and had low STI-related knowledge (87.7% vs 79.7%) ([Table 5](#pone.0234261.t005){ref-type="table"}).

Factors associated with asymptomatic CT infection among female participants {#sec012}
---------------------------------------------------------------------------

Risk factors associated with asymptomatic CT infection among female participants included females aged less than 30 years (aOR, 1.78; 95% CI, 1.24--2.55) ([Table 6](#pone.0234261.t006){ref-type="table"}).

10.1371/journal.pone.0234261.t006

###### Factors associated with asymptomatic CT infections among female participants.
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  Variables                     Univariate analysis   Multivariate analysis                           
  ----------------------------- --------------------- ----------------------- ----------------------- -----------
  Age, y                                                                                              
   \>30                         1                                             **1**                   
   ≤30                          1.96 (1.39--2.78)     0.001                   **1.78 (1.24--2.55)**   **0.002**
  Children                                                                                            
   NO                           1                                             1                       
   Yes                          0.64 (0.45--0.90)     0.011                   0.74 (0.48--1.15)       0.177
  Residence status                                                                                    
   Local residents              1                                             1                       
   Migrants                     1.91 (1.24--2.94)     0.003                   1.52 (0.95--2.43)       0.079
  Local residence time                                                                                
   0--12 months                 1                                             1                       
   Over 1 year                  0.83 (0.64--1.08)     0.168                   0.91 (0.69--1.19)       0.487
  Occupation                                                                                          
   Staff                        1                                                                     
   Commercial services          1.78 (1.08--2.92)     0.023                   1.46 (0.86--2.46)       0.160
   Housework or unemployed      1.07 (0.63--1.83)     0.802                   ―                       ―
   Worker                       1.86 (1.11--3.11)     0.018                   1.51 (0.87--2.63)       0.142
  Clinical settings                                                                                   
   Gynecological department     1                                             1                       
   Dermatological department    1.79 (0.90--3.59)     0.099                   2.02 (0.98--4.14)       0.056
   Family planning department   0.77 (0.45--1.30)     0.321                   ―                       ―
  Insurance                                                                                           
   Private/Medicaid             1                                             1                       
   Uninsured                    1.44 (1.01--2.04)     0.044                   1.05 (0.70--1.57)       0.809
  History of STI test                                                                                 
   No                           1                                             1                       
   Yes                          0.46 (0.20--1.05)     0.066                   0.56 (0.24--1.32)       0.182
  STI-related knowledge                                                                               
   Low                          1                                             1                       
   High                         0.55 (0.33--0.93)     0.026                   0.62 (0.36--1.08)       0.092

Discussion {#sec013}
==========

In this clinic-based multi-site cross-sectional study, we determined both the prevalence and proportion of laboratory-confirmed urethral CT and/or NG infections that were asymptomatic among subjects presenting to clinics in Shenzhen, China. Overall, the prevalence of asymptomatic NG infection was low, but a high prevalence of CT infection was observed among males and females who have no symptoms. In addition, we found that about one-third of CT infections among males or females with urethral CT were asymptomatic. For asymptomatic males with urethral CT, we identified 3 independent predictors: (1) males under the age of 30; (2) being employed in the commercial service work; and (3) being recruited through the urological department (vs dermatological department). For asymptomatic females with urethral CT, age less than 30 years was a risk factor.

The overall prevalence of CT and NG observed in this study was lower than that of Zhang et al\[[@pone.0234261.ref006]\] in 2009 in the similar population in Shenzhen but still significantly higher than the national level.\[[@pone.0234261.ref007]\] Currently, the cause for the decline in the prevalence of NG and CT are not clear, but these two pathogens (especially CT) are still serious public health problems in Shenzhen. A systematic review suggested that if the prevalence of CT is between 3.1--10.0%, the screening for CT infectious is cost-effective.\[[@pone.0234261.ref013]\] Our findings indicated that a regular and comprehensive CT screening is warranted in Shenzhen.

The proportion of asymptomatic NG and CT has been widely reported, but results vary widely around the world, ranging from 8% to 87%.\[[@pone.0234261.ref014]--[@pone.0234261.ref017]\] The disparities in the proportion of asymptomatic participants with or without STIs may be attributed to the different laboratory methods employed, the distribution of risk factors and the composition of the population studied. Given that one-third of CT infections are asymptomatic, passive screening in Shenzhen (i.e., screening patients for medical treatment) is not enough. We need to identify risk factors for patients with asymptomatic CT infections and conduct targeted screening across the entire population.

The mechanism for why some people infected with CT or NG are asymptomatic remains uncertain; it is possibly related to a low-level bacterial load.\[[@pone.0234261.ref018]\] Our epidemiological study has shown that participants (both males and females) under the age of 30 are associated with higher odds of a asymptomatic STI positive screening result. This is similar to the findings from other previous studies which investigated risk factors for the overall prevalence of NG or CT.\[[@pone.0234261.ref019]--[@pone.0234261.ref023]\] Some potential explanations for the impact of age on the prevalence of STI might be: first, youth are often accompanied by strong sexual desire, which results in frequent sexual activity; second, because of a lack of awareness of sexual safety, youth are more likely to engage in risky sexual behaviors. In view of this, some developed countries have launched STI screening programs for young adults.\[[@pone.0234261.ref020], [@pone.0234261.ref024], [@pone.0234261.ref025]\] Our findings suggest that attention should also be paid to asymptomatic STIs during the screening process.

Another noteworthy finding was that the prevalence of asymptomatic urogenital CT was significantly higher in male participants who were recruited through the urological department than that of male participants who were recruited through the dermatological department. In the past, STI screening services conducted by local government were always carried out with the dermatological department as the core place. However, our finding indicates that urological department may be a better site to offer male patients opportunistic screening for CT. So far, although most developed countries have implemented opportunistic screening services for STIs, the effectiveness of these services in reducing the prevalence of STIs has not been satisfactory.\[[@pone.0234261.ref020], [@pone.0234261.ref026], [@pone.0234261.ref027]\] Our results may provide room for improvement of STIs screening. In addition to the screening site, low uptake rates of STIs screening may also be one of the factors hindering the screening effectiveness. According to a study from the US, approximately 37.9% females reported ever receiving a CT testing.\[[@pone.0234261.ref028]\] In China, Wu et al\[[@pone.0234261.ref029]\] found that less than one-third of males had participated in a NG or CT testing. Surprisingly, we observed that the screening intention was significantly lower in male participants who were recruited through the dermatological department than that of male participants who were recruited through the urological department ([S1 Fig](#pone.0234261.s001){ref-type="supplementary-material"}). People with a higher willingness to screen are more likely to go to the urological department, which further supports the placement of screening sites for males in the urological department.

Our study has some limitations. First, our study was limited to clinics where participants who had urethral symptoms and who were at particularly high-risk of infection were more likely to go to the clinics for treatment. It is possible that the prevalence of NG and/or CT infections among participants without symptoms in the community will be overestimated. Thus, caution should be used when generalizing our findings to the community in Shenzhen. Second, the participants of the study were recruited using a convenient sampling method and the sampling period was only 1 month, which may also lead to a potential selection bias. Third, we limited the detection to urogenital specimens only, so extragenital infections were not captured. However, given that the high-risk population with rectal or oropharyngeal infections (such as MSM and sex workers) included in our study was rare, our data on prevalence of NG and/or CT infection were reliable. Finally, as with other cross-sectional studies, reporting bias, recall bias and limitation in making causal inferences should be considered.

In conclusion, a substantial prevalence of asymptomatic CT infection was found among males and females presenting to clinics in Shenzhen. The significant correlation between asymptomatic CT infection and age as well as clinical setting could help identify high-risk populations and guide resource allocation and screening. Future studies should investigate people's willingness to screen and the effectiveness of screening strategies on these high-risk populations.
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Major comments:

1\. Response to comment: The aim of the study was to determine prevalence of asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections and the risk factors associated with these infections. However, as the authors have already conceded that due to low a prevalence of N. gonorrhoeae in their study, the number of C. trachomatis and N. gonorrhoeae cases were combined therefore the risks factors associated with asymptomatic infection of each pathogen could not be independently determined. Could you discuss in your limitations the implications of this? I think the title of the study in that regard does not address the aims as the risk factors associated with asymptomatic C. trachomatis and N. gonorrhoeae were not independently determined in this study.

Response: Thank you for your comment. After careful consideration of the reviewer's comment, we think the reviewer's suggestion is very reasonable. Therefore, we re-analyzed the risk factors of asymptomatic infections of NG and CT. The detailed process is shown below.

Table R1, Table R2 and Table R3 are the analysis of risk factors for asymptomatic NG&CT, CT and NG infections in men, respectively. After comparing Table R1 and Table R2, we found that the identified risk factors did not change (the OR and 95% CI changed slightly). After analyzing the risk factors of asymptomatic NG infection (Table R3), we found that living arrangements status was a predictor. However, among the male participants in Shenzhen, there were only 10 asymptomatic NG cases, and the prevalence of asymptomatic NG infection was only 0.9%. Due to low prevalence, the upper and lower limits of the 95%CI of living arrangements status fluctuate greatly (0.01-0.37), resulting in reduced accuracy. Considering that asymptomatic NG infection among men is not a serious public health problem in Shenzhen, we think it is unnecessary to do factor analysis for NG infection among male participants in our study.

Table R4, Table R5 and Table R6 are the analysis of risk factors for asymptomatic NG&CT, CT and NG infections in women, respectively. After comparing Table R4 and Table R5, we found that the variable (clinical settings) was no longer a predictor and the OR value for age changed slightly. After analyzing the risk factors of asymptomatic NG infection (Table R6), we found that the clinical setting was a predictor. Similarly, we found that the upper and lower limits of the 95%CI fluctuate greatly (3.39-74.46). In addition, among female participants in Shenzhen, there were only 7 asymptomatic NG cases, and the prevalence of asymptomatic NG infection was only 0.4%. Therefore, we also think it is unnecessary to do factor analysis for NG infection among female participants in our study.

According to the above analysis, we think it is necessary to retain the prevalence and proportion of NG infection, but factor analysis for NG infection is not required. The original research purpose "The aims of this study were to investigate the prevalence and proportion of laboratory-confirmed urethral Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections that were asymptomatic among individuals presenting to clinics in Shenzhen and the risk factors related to these asymptomatic infections." has been changed to "The aims of this study were to investigate the prevalence and proportion of laboratory-confirmed urethral Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections that were asymptomatic among individuals presenting to clinics in Shenzhen and the risk factors related to asymptomatic CT infection.". Please see title, abstract (line 43) and line 111. In addition, in the results (risk analysis section), we only describe the results of factor analysis of asymptomatic CT infection. Please see line 199-line 204, line 207-line 211, line 222-line 227 and line 231-line 233.

2\. Response to comment: The authors determined one the risk factors for asymptomatic C. trachomatis / N. gonorrhoeae was recruitment from urology department (men) and dermatology (men). Did you include results from the other 46 departments in your analysis? In your results in Table 3 and 5 data from only three departments is shown.

Response: Thank you for your comment. This study mainly took STIs-related clinics as the study sites, because the individuals seeking medical services in these clinical settings are usually a high-risk group of STIs. This group has a heavy burden of STIs, which is sufficient to be considered a cost-effective intervention target for NG and CT infections. Therefore, the 49 departments in our study are all composed of dermatological department, gynecological department, urological department and family planning department. Our study included 22 hospitals. Among them, many are maternal and child health hospitals or centers for chronic disease control. These hospitals usually do not have urological department and family planning department. Therefore, 22 hospital (49 departments) were eventually included in our study.

3\. Response to comment: Results in table 2 and table 3 should also include the actual number of positive C. trachomatis and N. gonorrhoeae cases not just as "positive cases"

Response: "positive cases" has been modified to "positive CT cases". Please refer to the reply to comment 1 for the reason for modification.

Minor comments:

Response to comment: Line 42 and 80: "Chlamydia trachomatis" and "Neisseria gonorrhoeae" should always be in italics

Line 82: can you cite a more recent reference with up-to-date epidemiological information

Line 86: please add a reference to support mentioned statements

Line 150: "magnetism" should be "magnetic"

Line 264: "but these two diseases (especially CT)" please rephrase as CT and NG are bacterial names not diseases

Results: were there any participants with dual C. trachomatis or N. gonorrhoeae infections?

Response: We have made correction according to the reviewer's comment. Please see line 41, line 77, line 79, line 83, line 151 and line 252.

Among the male participants, there were 10 cases of dual infection of NG and CT, and the prevalence was 0.4%. Among the female participants, there were 3 cases of dual infection of NG and CT, and the prevalence was 0.2%. Due to the low prevalence, we did not describe them in the results.

Responds to the reviewer\#2's comments:

1\. Response to comment: Please clarify the selection process: Are these 6 districts reported more cases than the 4 who were not selected? (Line 121: First, we selected 6 out of the 10 administrative districts in Shenzhen based on the number of NG and CT cases reported in 2017).

Response: Thank you for your comment. We have made correction according to the reviewer's comment. Please see page 5, line 118- line 121.

2\. Response to comment: Please clarify the enrollment: (Line 127) The first 15 eligible individuals who arrived at each department were invited...), this is confusing, I guess should be "the first 15 eligible individual every working day" to participate in the questionnaire survey and urine collection

Response: Thank you for your comment. We have made correction according to the reviewer's comment. Please see page 5, Line 126.

3\. Response to comment: Definition of symptoms, as this is quite important and easy to cause bias. From the results, it seemed that symptomatic or asymptomatic were self-reported, the question is who made the judgement? Is any case or all cases examined by doctors? As patients may reported symptom-free, while doctor found urethral discharge during physical examination. In addition, urethritis or cervicitis are clinical diagnosis, and should be judged by clinical examination, please clarify this.

Response: Thank you for your comment. When the clinic attenders agreed to participate in the questionnaire, we first asked them to describe whether they felt uncomfortable. Then, regardless of whether the participants reported symptoms or not, a clinician would do a physical examination for the respondent and recorded the corresponding results. The definition of symptoms in this study was based on the doctor's examination results, so the results are reliable. In order to allow readers to understand our research more clearly, we have added this content in the method section, please see line 140-line 143.

4\. Response to comment: Please delete the repeated sentence: Line 181: The proportion of asymptomatic urethral NG in men with urethral NG was 7.2%; for women it was 16.3%. The proportion of asymptomatic

Response: Thank you for your comment. The sentences "The proportion of asymptomatic urethral NG in men with urethral NG was 7.2%; for women it was 16.3%. The proportion of asymptomatic urethral CT in men with urethral CT was 28.3%; for women it was 34.2%." have been deleted.

5\. Response to comment: In the results, a table which describe the characteristics of all participants will add more information to readers.

Response: Thanks to the Reviewer for this comment. The characteristics of all participants were shown in table 1.

6\. Response to comment: Table 1 is confusing, will be clearer to have: number of total tested, number of positive in total; number of asymptomatic, number of positive among asymptomatic, this could be further stratified by sex.

Response: We have made correction according to the Reviewer's comment. Please see table 2.

We tried our best to improve the manuscript and made some changes in the manuscript. These changes will not influence the content and framework of the paper. And here we did not list the changes but marked in red in revised paper. We appreciate for Editors/Reviewers' warm work earnestly and hope that the correction will meet with approval. Once again, thank you very much for your comments and suggestions.
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